Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20
Closed -$2K 364
2017
Q3
$2K Hold
20
﹤0.01% 227
2017
Q2
$1K Sell
20
-43
-68% -$2.92K ﹤0.01% 233
2017
Q1
$5K Sell
63
-179
-74% -$11.8K ﹤0.01% 241
2016
Q4
$14K Buy
+242
New +$12.8K 0.01% 224

Other funds holding ADNT

Whitnell & Co's ADNT Position: Q4 2017 in Review

Whitnell & Co sold out of Adient (ADNT) in Q4 2017, closing a stake of 20 shares — an estimated $2K sold.

Whitnell & Co first reported a position in ADNT in Q4 2016 and held it in 4 quarters. The position peaked at $14K in Q4 2016. 450 funds tracked by Wall St. Rank hold ADNT as of Q4 2017.

  • Whitnell & Co reported no remaining Adient position as of Q4 2017 after selling out during the quarter.
  • Whitnell & Co sold 20 Adient shares in Q4 2017, an estimated $2K.
  • Whitnell & Co first reported a position in Adient in Q4 2016 and held it in 4 quarters.
  • Whitnell & Co's Adient position peaked at $14K in Q4 2016.
  • 450 funds tracked by Wall St. Rank held Adient as of Q4 2017.

Based on Whitnell & Co's 13F filing for Q4 2017, filed 26 Jan 2018.